Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: billy d who wrote (1198)	9/23/1998 8:32:00 PM
From: Ed Ajootian	Respond to of 10280

Billy, I say we start an e-mail campaign to Tim Barberich (SEPR pres.) and David Southwell (CFO), where we spam the hell out of them with the following message: Great job guys, but SPLIT THE GODDAM STOCK, DAMMIT!!! Congrats to all SEPR bulls. The "long term" is finally here!

To: billy d who wrote (1198)	9/23/1998 8:43:00 PM
From: John Metcalf	Read Replies (2) \| Respond to of 10280

Good point, Billy d. There has been a tremendous biotech rally this September. In just 16 trading days, the $BTK (AMEX Biotech index) has risen from 104.5 on August 31 to 152.1 today, a gain of 46%. Gains have been concentrated in the larger companies, like Sepracor, Agouron, Millennium, and Biogen. I wish I could recommend a good fund -:) As an alternative, I suggest looking at some of the threads Rick Harmon has started at SI, including the T/FIF portfolio, the "bounce" portfolio, and the Biotech Value Fund thread.